Skip to content
← Full study record

NCT01010126 · MORE INFO

Limitations, agreements, and source contact

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · Source last updated 2019-01-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
pitot.henry@mayo.edu
organization
Mayo Clinic
phone
(507) 284-2511
title
Henry Pitot, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
pitot.henry@mayo.edu
organization
Mayo Clinic
phone
(507) 284-2511
title
Henry Pitot, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice